BSE filing, NSE: TEJNAKSH. Summary written from the filing by ALFA Finder's alert engine.
Tejnaksh Healthcare Ltd: key numbers
- Share price
- ₹12.89
- Market cap
- ₹26.18 Cr
- Revenue (annual)
- ₹10.79 Cr
- Net profit (annual)
- ₹1.23 Cr
- P/E (TTM)
- 21.2×Sector 51.1×
- Promoter holding
- 73.83%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tejnaksh Healthcare Ltd
All →Tejnaksh Healthcare Business Update
Tejnaksh Healthcare announced publication of a multicentric validation study of its Pflow device in the Indian Journal of Urology. The filing is a scientific publication update with no financial value.
Tejnaksh Healthcare Other Announcement
Tejnaksh Healthcare Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31(1)(b) of SEBI LODR.
Tejnaksh Healthcare Annual General Meeting
The company issued a notice for its Annual General Meeting scheduled for September 29, 2026, to consider financial statements, director appointments, and related party transaction approvals.
Tejnaksh Healthcare Annual Report
Tejnaksh Healthcare Limited has submitted its Annual Report for the financial year 2025-26. The filing includes audited standalone and consolidated financial statements along with governance reports.
Tejnaksh Healthcare Annual General Meeting
Tejnaksh Healthcare Ltd will hold its 19th Annual General Meeting on September 29, 2026. The meeting will be conducted via video conferencing to transact ordinary and special business.
Tejnaksh Healthcare Q1 FY27 Results: Net Profit ₹0.3 Cr, Up 50.0% YoY
Tejnaksh Healthcare Ltd reported revenue from operations of ₹2.7 Cr (+3.8% YoY) and net profit of ₹0.3 Cr (+50.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · +50.0% YoY
Other management change announcements
All →Sagarsoft (India) Management Change
Sagarsoft (India) appointed Ms. Arcot Ganeshan Monisha as Company Secretary and Compliance Officer, designated as KMP, effective 28 October 2026. Details are provided per Regulation 30 in the annexure.
Chemfab Alkalis Management Change
Chemfab Alkalis approved unaudited Q2/H1 results, committee re-designations, and appointed V. R. Raguraman as Chief Operating Officer (SMP). The senior management appointment is the filing's main business event.
Aeroflex Industries Management Change
Aeroflex Industries reports Drashti Bhil's change from Deputy CFO to CFO, plus Mustafa Kachwala's tenure completion as CFO effective 27 November 2026. Management reshuffle with no money or business event.
Chandra Prabhu International Management Change
Chandra Prabhu International resignation of Mrs. Vandana Singh, Additional Director, accepted effective close of business 28 October 2026. Filed as per SEBI Master Circular disclosure requirements.
Hexagon Nutrition Management Change
Hexagon Nutrition shareholders approved Arun Purushottam Kelkar as Executive Director and Chairman, effective October 28, 2026. He has been with the company since its incorporation.
- Execution
- 5 years
Mercury Laboratories Management Change
Mercury Laboratories disclosed the cessation of Manager-HR Jaydeepsinh Raj, effective October 28, 2026. The employee stopped reporting for duty without prior intimation to the company.